Medical Support System for iPS Cell Production Probability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current regenerative medicine technologies face challenges in addressing individual differences in cell production and immune rejection, making it difficult to provide high-quality autologous transplantation services effectively.
Innovation Solution
A medical support system that acquires biometric data from patients to estimate the probability of success in induced pluripotent stem (iPS) cell production and differentiation, using this information to provide personalized regenerative medicine services by predicting future cell production capabilities and optimizing treatment timing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If allogeneic transplantation is performed to find a donor with matching HLA type, then the risk of immune rejection is reduced, but there are certain limitations in further reducing the risk and it requires finding a suitable donor which takes time and may not always be successful
Solution Approach 1:
Instead of finding a donor that matches the patient (allogeneic approach), the invention inverts the approach by using the patient's own cells (autologous approach). The system reprograms the patient's somatic cells into iPS cells, which are then differentiated into desired cell types for transplantation. This eliminates the need to search for HLA-matched donors and completely avoids immune rejection risks.
2Reliability
If autologous transplantation using patient's own cells is implemented to avoid immune rejection risk, then immune rejection is avoided, but it is difficult to provide high-quality services effectively due to individual differences in cell production
Solution Approach 1:
The system performs preliminary assessment of the patient's cell production probability before initiating the iPS cell production process. By evaluating biometric data and calculating the probability of successful cell production in advance, the system can identify patients who are suitable candidates for autologous transplantation and provide counseling on optimal timing, thereby ensuring high-quality service delivery despite individual variations.
Solution Approach 2:
The system provides feedback to patients about their individual cell production probability based on their biometric data. This feedback mechanism allows patients to understand their personal characteristics and make informed decisions about when to proceed with treatment, enabling the system to effectively manage individual differences and maintain high service quality.
3Productivity
If the system assesses and provides personalized information on cell production probability, then service quality is improved by addressing individual differences, but the complexity of the system increases due to data acquisition and analysis requirements
Solution Approach 1:
The invention introduces an information processing apparatus as an intermediary between the patient's biometric data and the treatment decision-making process. This apparatus automatically acquires biometric data, calculates cell production probability using predefined algorithms, and provides personalized recommendations. By automating the assessment process, the system manages complexity while delivering high-quality personalized services.
Data Source
AI summary
A medical support system according to an embodiment includes processing circuitry and a display. The processing circuitry acquires biometric data of a subject to be examined or treated. The processing circuitry generates information on the probability of success in cell production in the future based on biological samples of the subject, on the basis of the biometric data. The display displays information on the probability of success in cell production in the future.